Accurate sequence information is essential to the design of the primers and probes that are critical to the success of polymerase chain reaction (PCR) assays and Real-Time PCR. The continuing genetic evolution and diversity of infectious diseases and emerging pathogens are therefore a significant challenge for PCR assays. In fact, monitoring and responding to sequence changes is essential for companies that produce effective assays. It should be no surprise that Roche Molecular Diagnostics, a pioneer in PCR technology, is also a global leader in monitoring these sequence changes.